Results 11 to 20 of about 7,440,138 (398)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

open access: yesMolecules, 2023
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended in almost all countries, except China, with COVID-19 being likened to the flu. In this context, the U.S.
B. G. de la Torre, F. Albericio
semanticscholar   +1 more source

Phenolic Constituents from the Stems of Morus nigra and their α-Glucosidase Inhibitory Activities

open access: yesPharmaceutical Fronts, 2021
A new sanggenon-type flavanone, nigragenon F (1), together with 11 known compounds, trans-resveratrol (2), (E)-4-isopentenyl-3,5,2′,4′-tetrahydroxystilbene (3), notabilisin E (4), notabilisin A (5), morusin (6), petalopurpurenol (7), 8-geranyl-5,7 ...
Ling-Ling Wang   +5 more
doaj   +1 more source

Behind the French controversy over the medical treatment of Covid-19: The role of the drug industry

open access: yesJournal of Sociology, 2020
This article explores the stakes of the very intense controversy that has developed in France around the medical treatment of Covid-19 (which finds some parallels in the United States of America).
L. Mucchielli
semanticscholar   +1 more source

Enhanced Efficacy and Reduced Hepatotoxicity by Combination of Gnaphalium affine Extract and Benzbromarone in the Treatment of Rats with Hyperuricemic Nephropathy

open access: yesPharmaceutical Fronts, 2021
Simultaneous oral intake of herbal medicine with chemical drugs may result in beneficial pharmacodynamic efficacy, including additive and synergistic effects with reduced toxicity. Gnaphalium affine D. Don (GAD) is a traditional Chinese Medicine that has
Fei Liu   +4 more
doaj   +1 more source

Natural products in drug discovery: advances and opportunities

open access: yesNature reviews. Drug discovery, 2021
Natural products and their structural analogues have historically made a major contribution to pharmacotherapy, especially for cancer and infectious diseases.
A. Atanasov   +73 more
semanticscholar   +1 more source

GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study

open access: yesBJGP Open, 2021
Background: The pharmaceutical industry invests heavily in promoting medications to physicians. This promotion may influence physicians’ prescribing behaviour and lead to inappropriately increased prescribing rates.
James Larkin   +5 more
doaj   +1 more source

Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

open access: yesPolymers, 2023
In the last four decades, nanotechnology has gained momentum with no sign of slowing down. The application of inventions or products from nanotechnology has revolutionised all aspects of everyday life ranging from medical applications to its impact on ...
Azeez Yusuf   +4 more
semanticscholar   +1 more source

Applications of single-cell RNA sequencing in drug discovery and development

open access: yesNature reviews. Drug discovery, 2023
Single-cell technologies, particularly single-cell RNA sequencing (scRNA-seq) methods, together with associated computational tools and the growing availability of public data resources, are transforming drug discovery and development.
Bram Van de Sande   +16 more
semanticscholar   +1 more source

Pharmaceutical procurement among public sector procurers in CARICOM

open access: yesRevista Panamericana de Salud Pública, 2021
Objective. To examine multiple aspects of the medicines in CARICOM procurement markets, including manufacturer headquarters location, regulatory history, and type (innovator versus generic); the proportion of World Health Organization (WHO) essential ...
Charles Preston   +4 more
doaj   +1 more source

Procedure for Reviewing Pharmaceutical Inspections in the Eurasian Economic Union (Review)

open access: yesРазработка и регистрация лекарственных средств, 2021
Introduction. The article discusses significant changes in the procedure for pharmaceutical inspection of drug manufacturers for compliance with the requirements of the rules of good manufacturing practice (GMP) of the Eurasian Economic Union (EAEU ...
A. P. Meshkovskiy   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy